Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies

MLA

Wilhelm A. J. W. Vos, et al. “Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-Nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies.” Viruses, vol. 16, no. 4, Apr. 2024, p. 582. EBSCOhost, https://doi.org/10.3390/v16040582.

APA

Wilhelm A. J. W. Vos, Nadira Vadaq, Vasiliki Matzaraki, Twan Otten, Albert L. Groenendijk, Marc J. T. Blaauw, Louise E. van Eekeren, Kees Brinkman, Quirijn de Mast, Niels P. Riksen, Anton F. H. Stalenhoef, Jan van Lunzen, Andre J. A. M. van der Ven, Willem L. Blok, & Janneke E. Stalenhoef. (2024). Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies. Viruses, 16(4), 582. https://doi.org/10.3390/v16040582

Chicago

Wilhelm A. J. W. Vos, Nadira Vadaq, Vasiliki Matzaraki, Twan Otten, Albert L. Groenendijk, Marc J. T. Blaauw, Louise E. van Eekeren, et al. 2024. “Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-Nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies.” Viruses 16 (4): 582. doi:10.3390/v16040582.